» Articles » PMID: 36291357

Association of Type 2 Deiodinase Thr92Ala Polymorphism with Pediatric Obesity in Japanese Children: A Case-Control Study

Overview
Specialty Health Services
Date 2022 Oct 27
PMID 36291357
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic factors play critical roles in the onset and progression of obesity. Brown adipose tissue (BAT) activity is also critical for adiposity. The objective of this study was to evaluate the prevalence and effects of BAT gene polymorphisms in pediatric obesity. This case-control study included 270 non-obese and 86 obese children. All participants underwent genotyping for type 2 deiodinase (DIO2) Thr92Ala (rs225014). The prevalence of the homozygous Ala/Ala allele of the DIO2 gene in the obese group was 15.1% versus 6.3% in the non-obese group, resulting in an odds ratio (OR) of 3.393 ( = 0.003). The results of this study indicate that the homozygous Ala/Ala allele of the DIO2 gene is associated with an increased risk of pediatric obesity and suggest that pediatric obesity might be suitable for assessing the association with gene polymorphisms related to BAT, especially DIO2 Thr92Ala.

References
1.
Luongo C, Dentice M, Salvatore D . Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol. 2019; 15(8):479-488. DOI: 10.1038/s41574-019-0218-2. View

2.
Maes H, Neale M, Eaves L . Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997; 27(4):325-51. DOI: 10.1023/a:1025635913927. View

3.
Kawabe Y, Mori J, Morimoto H, Yamaguchi M, Miyagaki S, Ota T . ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue. Am J Physiol Endocrinol Metab. 2019; 317(6):E1140-E1149. DOI: 10.1152/ajpendo.00311.2019. View

4.
Dobashi K . Evaluation of Obesity in School-Age Children. J Atheroscler Thromb. 2015; 23(1):32-8. DOI: 10.5551/jat.29397. View

5.
Hauerslev M, Narang T, Gray N, Samuels T, Bhutta Z . Childhood obesity on the rise during COVID-19: A request for global leaders to change the trajectory. Obesity (Silver Spring). 2021; 30(2):288-291. PMC: 8662111. DOI: 10.1002/oby.23307. View